4EGI-1
10mM in DMSO
- Product Code: 181256
CAS:
315706-13-9
| Molecular Weight: | 451.28 g./mol | Molecular Formula: | C₁₈H₁₂Cl₂N₄O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
4EGI-1 is primarily used in biomedical research as a small molecule inhibitor that disrupts the interaction between eIF4E and eIF4G, two key proteins involved in the initiation of cap-dependent mRNA translation. By selectively targeting this protein-protein interface, 4EGI-1 effectively suppresses the translation of specific mRNAs that are critical for cell proliferation and survival, particularly those encoding oncoproteins such as cyclins and c-Myc. This makes it a valuable tool in cancer research, especially in studies focused on understanding translational control in tumor growth and identifying potential therapeutic strategies for malignancies driven by dysregulated protein synthesis. Additionally, 4EGI-1 has been used to probe the role of eIF4F complex formation in viral replication, as many viruses rely on the host’s cap-dependent translation machinery. Its application remains confined to laboratory settings, mainly in cell-based assays and preclinical studies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿7,100.00 |
+
-
|
4EGI-1
4EGI-1 is primarily used in biomedical research as a small molecule inhibitor that disrupts the interaction between eIF4E and eIF4G, two key proteins involved in the initiation of cap-dependent mRNA translation. By selectively targeting this protein-protein interface, 4EGI-1 effectively suppresses the translation of specific mRNAs that are critical for cell proliferation and survival, particularly those encoding oncoproteins such as cyclins and c-Myc. This makes it a valuable tool in cancer research, especially in studies focused on understanding translational control in tumor growth and identifying potential therapeutic strategies for malignancies driven by dysregulated protein synthesis. Additionally, 4EGI-1 has been used to probe the role of eIF4F complex formation in viral replication, as many viruses rely on the host’s cap-dependent translation machinery. Its application remains confined to laboratory settings, mainly in cell-based assays and preclinical studies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :